Julien Bohé

2.5k total citations
16 papers, 1.1k citations indexed

About

Julien Bohé is a scholar working on Epidemiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Julien Bohé has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Julien Bohé's work include Sepsis Diagnosis and Treatment (8 papers), Immune Response and Inflammation (6 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Julien Bohé is often cited by papers focused on Sepsis Diagnosis and Treatment (8 papers), Immune Response and Inflammation (6 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Julien Bohé collaborates with scholars based in France and Belgium. Julien Bohé's co-authors include Guillaume Monneret, Alain Lepape, Fabienne Venet, Jacques Bienvenu, Anne‐Lise Debard, Nicolas Voirin, François Gueyffier, Philippe Vanhems, Olivier Héquet and Alexandre Pachot and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Journal of Applied Physiology.

In The Last Decade

Julien Bohé

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julien Bohé France	10	688	618	228	115	111	16	1.1k
Anne‐Lise Debard France	14	1.0k 1.5×	825 1.3×	293 1.3×	97 0.8×	170 1.5×	15	1.6k
Stephen Jarman United States	3	756 1.1×	815 1.3×	328 1.4×	155 1.3×	223 2.0×	4	1.4k
Jonas Sundén‐Cullberg Sweden	15	373 0.5×	479 0.8×	124 0.5×	112 1.0×	205 1.8×	22	1.1k
John Constant United States	5	353 0.5×	469 0.8×	156 0.7×	154 1.3×	191 1.7×	10	951
Brittany Mathias United States	12	331 0.5×	396 0.6×	213 0.9×	135 1.2×	112 1.0×	14	860
Gerry S. San Pedro United States	4	346 0.5×	497 0.8×	172 0.8×	151 1.3×	158 1.4×	8	936
Charles J. Grodzin United States	4	253 0.4×	355 0.6×	138 0.6×	153 1.3×	99 0.9×	8	821
Roger C. Bone United States	7	359 0.5×	408 0.7×	156 0.7×	174 1.5×	137 1.2×	8	1.1k
Patrick Lahni United States	20	379 0.6×	511 0.8×	109 0.5×	157 1.4×	272 2.5×	51	1.1k
Mark W. Hall United States	11	228 0.3×	481 0.8×	162 0.7×	304 2.6×	55 0.5×	12	924

Countries citing papers authored by Julien Bohé

Since Specialization

Citations

This map shows the geographic impact of Julien Bohé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Bohé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Bohé more than expected).

Fields of papers citing papers by Julien Bohé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Bohé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Bohé. The network helps show where Julien Bohé may publish in the future.

Co-authorship network of co-authors of Julien Bohé

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Bohé. A scholar is included among the top collaborators of Julien Bohé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Bohé. Julien Bohé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Dargent, Auguste, Abderrahmane Bourredjem, Marine Jacquier, et al.. (2025). Dexmedetomidine to Reduce Vasopressor Resistance in Refractory Septic Shock: α2 Agonist Dexmedetomidine for REfractory Septic Shock (ADRESS): A Double-Blind Randomized Controlled Pilot Trial. Critical Care Medicine. 53(4). e884–e896. 3 indexed citations

Conrad, Anne, Damien Dupont, Jérôme Guitton, et al.. (2024). Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for Candida infections. Antimicrobial Agents and Chemotherapy. 68(11). e0099124–e0099124. 1 indexed citations

Vacheron, Charles‐Hervé, Arnaud Friggeri, Jean Iwaz, et al.. (2020). A new simplified and accurate sa-SOFA score. Journal of Critical Care. 57. 240–245. 6 indexed citations

Bourguignon, Laurent, Stanislas Ledochowski, Nacim Ammenouche, et al.. (2018). Determinants of amikacin first peak concentration in critically ill patients. Fundamental and Clinical Pharmacology. 32(6). 669–677. 5 indexed citations

Cour, Martin, Romain Hernu, Thomas Baudry, et al.. (2015). Long-Term Outcome of Critically Ill Adult Patients with Acute Epiglottitis. PLoS ONE. 10(5). e0125736–e0125736. 21 indexed citations

Timsit, Jean‐François, Lila Bouadma, Olivier Mimoz, et al.. (2013). Jugular versus Femoral Short-Term Catheterization and Risk of Infection in Intensive Care Unit Patients. Causal Analysis of Two Randomized Trials. American Journal of Respiratory and Critical Care Medicine. 188(10). 1232–1239. 43 indexed citations

Voirin, Nicolas, et al.. (2009). Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Medicine. 35(11). 1859–1867. 85 indexed citations

Monneret, Guillaume, Nicolas Voirin, Irène Krawice-Radanne, et al.. (2007). Soluble human leukocyte antigen-G5 in septic shock: Marked and persisting elevation as a predictor of survival. Critical Care Medicine. 35(8). 1942–1947. 27 indexed citations

Monneret, Guillaume, Alain Lepape, Nicolas Voirin, et al.. (2006). Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Medicine. 32(8). 1175–1183. 385 indexed citations

10.

Venet, Fabienne, Julien Bohé, Anne‐Lise Debard, et al.. (2005). Both percentage of γδ T lymphocytes and CD3 expression are reduced during septic shock. Critical Care Medicine. 33(12). 2836–2840. 50 indexed citations

11.

Venet, Fabienne, Alexandre Pachot, Anne‐Lise Debard, et al.. (2004). Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25− lymphocytes. Critical Care Medicine. 32(11). 2329–2331. 152 indexed citations

12.

Pachot, Alexandre, Guillaume Monneret, Nicolas Voirin, et al.. (2004). Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clinical Immunology. 114(1). 61–69. 77 indexed citations

13.

Monneret, Guillaume, et al.. (2004). INVOLVEMENT OF REGULATORY T CELLS (CD4+CD25+) IN SEPSIS-INDUCED IMMUNOPARALYSIS.. Shock. 21(Supplement). 52–52. 1 indexed citations

14.

Monneret, Guillaume, Anne‐Lise Debard, Fabienne Venet, et al.. (2003). Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Critical Care Medicine. 31(7). 2068–2071. 229 indexed citations

15.

Bohé, Julien, Emmanuel Combourieu, Christian Pommier, et al.. (2003). Sigmoidal equation for lung and chest wall volume-pressure curves in acute respiratory failure. Journal of Applied Physiology. 95(5). 2064–2071. 20 indexed citations

16.

Bendjelid, Karim, et al.. (2000). [Acute dissection of the ascending thoracic aorta complicated by myocardial infarct: an unavoidable diagnostic pitfall?].. PubMed. 29(22). 1220–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact